home / lobbying / lobbying_filings_raw

lobbying_filings_raw: f4b6a159-9df0-4a1d-a5fe-d1f9fa3d79f5

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
f4b6a159-9df0-4a1d-a5fe-d1f9fa3d79f5 Q2 40011075 ENDO INTERNATIONAL 187592 ENDO INTERNATIONAL 2011 second_quarter 2011-07-12T20:58:45.167000-04:00 510000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/f4b6a159-9df0-4a1d-a5fe-d1f9fa3d79f5/", "filing_uuid": "f4b6a159-9df0-4a1d-a5fe-d1f9fa3d79f5", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2011, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f4b6a159-9df0-4a1d-a5fe-d1f9fa3d79f5/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "510000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "James Brian Munroe, Vice President, Government Affairs", "dt_posted": "2011-07-12T20:58:45.167000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "499 South Capitol St., SW", "registrant_address_2": "Suite 608A", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20003", "registrant": {"id": 40011075, "url": "https://lda.senate.gov/api/v1/registrants/40011075/", "house_registrant_id": 39892, "name": "ENDO INTERNATIONAL", "description": "Pharmaceutical company", "address_1": "1400 Atwater Drive", "address_2": null, "address_3": null, "address_4": null, "city": "Malvern", "state": "PA", "state_display": "Pennsylvania", "zip": "19355", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MATTHEW MALETTA", "contact_telephone": "+1 484-216-0000", "dt_updated": "2024-01-22T10:00:17.332867-05:00"}, "client": {"id": 187592, "url": "https://lda.senate.gov/api/v1/clients/187592/", "client_id": 12, "name": "ENDO INTERNATIONAL", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "PA", "state_display": "Pennsylvania", "country": "US", "country_display": "United States of America", "ppb_state": "PA", "ppb_state_display": "Pennsylvania", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2008-02-15"}, "lobbying_activities": [{"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Patent reform issues (H.R. 1249, S. 23); Pattent settlements (S. 27).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39064, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "BRIAN", "last_name": "MUNROE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Drug reimportation issues (S. 319); Reauthorization of Prescription Drug User Fee Act; Life sciences research tax credit legislation; Healthcare reform bill repeal (H.R. 2); Orphan drugs issues; Drug Shortage issues (S. 296); medical liabilty reform.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39064, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "BRIAN", "last_name": "MUNROE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} PA US 39892 PA PA US US   0 0        

Links from other tables

  • 2 rows from filing_uuid in lobbying_activities
  • 1 row from filing_uuid in lobbying_lobbyists
  • 0 rows from filing_uuid in lobbying_affiliated_orgs
Powered by Datasette · Queries took 0.837ms